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To estimate prothrombin, two kinds of assay are in current use: the one-stage and
the two-stage assay. It, has been shown that the one-stage assay measures the initial
reaction velocity of the prothrombin conversion (Hemker and Muller, 1968). This reac-
tion velocity expresses itself in a clotting time and therefore escapes (bio-)chemical
standardization. One has to make do with comparative estimations in which the pro-
thrombin content is expressed as a percentage of a standard normal plasma.
In the two-stage assay the prothrombin from the'sample is converted into thrombin,
after which this thrombin is measured. Since thrombin is a weli-defined serine-esterase
whose concentration can be standardized, the two-stage procedure must be considered
to be preferable. Moreover, there is evidence that the two-stage assay does not measure
the same reactant as the one-stage assay does.
Although in dilutions of normal plasma and in parenchymatous liver disease both
tests run fairly parallel, in oral anticoagulant treatment and in vitamin K deficiency,
the two-stage assay gives results that are up to 20o/o higher than those obtained with
the one-stage assay (Hemker, Muller and Loeliger, 1970). Since prothrombin is defined
as the zymogen (or zymogens) giving rise to thrombin (or thrombins), this discrepancy
should not pass without notice. In our attempts to study it further, we encountered
the di{ficulty that no satisfactory way of evaluating the results of a two-stage assay
exists. The problem resides in the fact that the amount of active thrombin present at
any moment in a coagulation mixture is the result of the thrombin-generating and the
thrombin-removing processes. But what one is interested in, is the amount of thrombin
that rvould eventually develop if no thrombin-removing processes were going on. This
quantity is usually calculated from the experimental data in either of two ways:
1. the Engiish method, which measures the area under the thrombin qeneration
curve (Biggs and Macfarlane, 1967);
2. the American method, which measures the maximal amount of thrombin ob-
served in the coagulation mixture (Wagner et al., 1965).
Both methods are recognized by the authors to give significant results only when
the experimental conditions are rigorously standardized. It is the purpose of this
communication to propose a way of evaluation of the two-stage assay that gives a
figure for ihe potential thrombin yield that is minimally influenced by the prevailing
experimental conditions (concentration of antithrombin, prothrombin etc.).
Materials anil Methotls
Norrnal plasmo is a pooled normal plasma obtained from 30 healthy donors, mean age 30 years.
9 parts of blood are collected in 1 part of tri Na-citrate 2 aq., so as to obtain a final concentration of
0.8olo (w/v).
Thromhoplasti'n is human brain thromboplastin prepared according to Owren and Aas (1961).
Thrombos. Diathes. haemorrh. (Stuttg.)
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A 5 ml aliquot of normal plasma was diluted 1: 8 with twice-distilled water. Tho pI[ was brought
to 5.4 wifh lo/o a"celic acid, The sedirnent was obtained by contrifugatioir (10 rnin, 12,000 g, 4' C)
and dissolved in 2.5 ml Micha6lisbuffer (pH 7.4). The prothrombin contont was 175lo (of the
normal plasma) [one-stage estimation actording to Loeliger (1952)]. The antithrombin III concen-
tration was less tlra,n Llo (estimated according to Ilenson and Loeliger, 1963).
Thrombin Preparatiom
A 2.5 ml aliquot of tho ouglobulin preparation was incubated at 37o C with 0.5 ml CaCl, solution
(33 mM) and 0.5 ml thromboplastin, diluted 1:10, until no further rise in ihrombin concentration
was observed. This preparation still contains many impurities, notably coagulation factors. Theso
do not play a rolo, however, under fhe conditions in which the thrombin reforenco curve was
determined.
The two-stage assaA was carried out as follows. A 0.5 ml aliquot of the sample was diluted 1:5
with 2 ml Micha,dlisbuffer (pH 7.4), to which Na-citrate was added to a final concentration of 0.8o/o
(w/v). One ml of this mixture was added to 1 ml human brain thromboplastin diluted 1: 10 with
Michaelisbuffer (pH 7.4) and 1 mI CaOlr-solution (33 mM). This mixture was incubated at 20o C or
37' C. At one-minute intervals, 0,1 m1 was subsa,mpled into 0.1 ml BaSOn-adsorbed oxalated
bovine plasma diluted 1:5, and the coagulation time was recorded,
Ilhe thrombin reJerence curaewas prepared by making serial dilutions of the thrombin preparation
(t l r , t ln ,  I /uetc.downto 1/ . r ) ,andest imat ingtheclot t ingt imeof 0.1ml of  th isdi lut ionwith0. lml
of BaSOn-adsorbed oxalated bovine plasma diluted 1:5. With the aid of this curve, thrombin
times obtainod.in the two-stage a,ssay wero converted into arbitra,ry units (A.U.) of thrombin. The
curve of thrombin concentration, plotted against incubaf,ion time, is called tho thrombin genera-
tion curvo,
Theoretical Considerations
The thrombin present in the reaction mixture of a two-stage assay is the result of
two competing reactions: the thrombin formation and the thrombin ind,ctivation.
The thrombin formation is a further undefined function of time. Let Q(t) represent
the amount of tbrombin that has been generated at time t, although it may have been
inactivated subsequently. n'rom the experiment we want to obtain Q(tu), i.e. the
amount of thrombin that would eyentually develop at the end of the experiment, if
all the prothrombin were conyerted into thrombin and no inactivation oacurred. The
velocity of thrombin generation, not considering the breakdown, is given by the first
derivative of Q, i.e. Q'.
Thrombin is removed from the incubation mixture according to the reaction:
thrombin { antit'hrombin III + metathrombin. It has been shown (Hensen ahd Loe-
liger, 1963) and it will also follow from the experimental part of this paper, that a) this
rea,ction can be considered to be the only significant thrombin-removing reaction
under the circumstances of the test, and b) that in this reaction the law of mass action
holds, and that antithrombin III is present in sufficient amounts to make the reaction
a pseudo-unimolecular one, so that the breakdown velocity at time t is given by
b ( t )  :  k .A.T ( t )  (1)
where A is the antithrombin III concentration and T (t) is the actual thrombin con-
centration at time t. It follows that the change in concentration of active thrombin (T)
at time t is given by the rate of accumulation of total thrombin minus the rate of its
deEradation
# - e'(t) - k.A.r (t) (2)
!t
I
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The American way of evaluating a two-stage assay consists of measuring the
amount of active thrombin (T) at the moment (say s) that this amount reaches its
maximum value. By definition at this moment s there is no change in the concentra-
tion of active thrombin:
# : 0, so that Q' (s) : k'A'T (s) and T (s) : +* (3)
X'rom formula (3) it is obvious that the maximal amount of thrombin found [T (s)] is
inversely proportional to the concentration of antithrombin III present, and therefore
cannot be a reasonable measure of Q (t"), because this quantity has to bp proportional
to the prothrombin content only.
Rearrangement of formula (2) gives
1  d T -r  ( t)  :  r .e. tQ'(r)  -  ; ;  r
What is estimated by measuring the surface (S) under the thrombin generation
curve is (by definition)
S : f'" fat (t. : time at the end. of the experiment)
s o  o J  
^  f r "  r  - ^ . . . .  d r  -  , .s : ,J kA ta'(r)  -  ; ;  I  dt
l u e
I  Q' ,( t )  dt  -
OJ ./'"# u'
,lt" n'(t) dt : e (t") - e (o)
s -
k .A .k.A.
by definition
and
f *+dt : r ( te)- r (o)  (5)
oJ 0t
T (0) : Q (0) is the amount of thrombin present atzero time and T (tu) is the amount
actually present at the end of the experiment. Both these values ate zero, so formula (5)
and therefore the last term of formula (4) equal zero; thus
1
s : k A  Q ( t . )  ( 6 )
It is evident that the surface S is proportional to Q (t") and therefore to the pro-
thrombin content of the sample, but that is also is inversely proportional to A, i. e. to
- 
the antithrombin III content of the sample. S is therefore not a useful quantity to
T reflect Q (tu). In all dilutions of a given sample S will have to be equal, because the
proportion of Q (t") to A is fixed. In the experimental section this will indeed be shown
I to be the case.r It is generally known that the generation of thrombin is a relatively quick process.
This must mean that for all practical purposes Q (t") is reached long before the end of
the experiment. From that moment on, the thrombin generation curve reflects only
the decay process. If this is an adequate approximation, and i{ the description of the
decay process by the action of antithrombin III only is also a fair enough represen-
tation of reality, we should get a good. impression of the decay process from the last
(declining) part of the thrombin generation curve. This would enable us to estimate
Q (t.) according to the following reasoning:
(4)
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If the last part of the reaction follows a pseudo-unimolecular course, it must show a
straight-line relationshrp on a plot of log T versus incubation time (t), because when
b (t) : k. A. T5 it follows that lnT : lnTo - k. A. t. In that case, linear extrapolation
to t : 0 would approximate the theoretically maximal amount of thrombin with which
the decay started, i.e. the amount that would have been present if no decay process
had been going on.
It must be stated explicitely that this procedure only approximates Q (te). It would
be theoretically correct only when all thrombin was indeed generated at zero time.
Under actual circumstances it can be foretold to underestimate the real Q (t") because
the prothrombin not yet converted to thrombin during the first moments of the reac-
tion is immune to the action of antithrombin III. The more the time needed for genera-
tion of thrombin is short compared to the time in which a semilogarithmic decay is
operative, the less the importance of this complication will be. The complication can
be overcome. X'rom the linear part of the dormslope of the plot of T versus t ; k. A. can
be estimated. As shou.n above fformula (6)] the surface (S) under a curve of T against t
equals Q (te)/k.A. An exact estimate of Q (t") is therefore given by S.k.A. This ap-
proach involves multiplication of experimental data, and therefore increases the error.
Moreover, it would be a tedious procedure. We therefore prefer to investigate the prac-
tical usefulness of the quick approximation obtained by logarithmic extrapolation.
The rcoints to be tested experimentally are:
a) the decay part of a tlirombin generation curve is a straight line when log T is
plotted against incubation time;
b) the time lapse during which semi-logarithmic decay is observed is long compared
to the phase of thrombin generation;
c) the reaction constant of decay is proportional to the amount of antithrombin III
present;
d) extrapolation of the log T versus t-plot to t : 0 approximates Q (t"); the value
thus obtained therefore approximates the concentration of thrombin that would have
been obtained if no antithrombin III had been present, or in other words, the equi-
valent of the original prothrombin content of the sample.
Experimental Results
Fig. 1 represents specemina of the conventional thrombin generation curves that
were used as an experimental basis. Table 1 shows that in a series of dilutions of the
same normal nlasma the surface under the curve is indeed constant within the limits
of the experimental error. n'or the surfaces obtained with low plasma dilutions, a ten-
dency to decrease is often observed.
This is readily explained by the fact that below a certain limit thrombin concentra-
tions are often neglected. The area thus discarded with a low-rising but long-lasting
curve as obtained with low plasma concentrations is therefore appreciably greater
than the area neglected of step-rising and rapidly descending curves. ft may be men-
tioned here in passing that to estimate surfaces under this kind of curves it is not
necessaryto proceedthrough the laborious methods of paper-weighing, square-counting
or planimetering. It can be easily proven that it is sufficient to acld all the thrombin
concentrations obtained, provided the sampling times are regularly spaced.
In contrast to the surface areas, the heights of the peaks do, as would be expected,
show a certain correlation with the amount of prothrombin originally present. They
are not, however, a fair representation of this amount. Moreover, estimation of peak
height means the selection of one thrombin estimation from the whole series as the:
I
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X'ig. 1. Thrombin generation curves plotted in a normal graph. (Experiments carried out at 37" C.)
I Undiluted normal plasma sample. ! 1:2 dilution, O 1:3 dilution.
Table 1. Surface area and maximal heighf of thrombin generation curves obtained with dilutions of
normal plasma,
Dilution Surface area(%) Peak height(%) Expected value
1 : 1
223
l : 2
1 : 3
I : 4
100
109
112
92
98
100
83
62
49
46
. 
100
66
50
33
25
The surfaco a,reas as well as the peak heights are oxpressed as I percentage of those obtained with
an undilutod sample,
representative value, the other data being d.iscard.ed. This procedure tends to gteatly
enhance the experimental error, the more so because the thrombin senetation curvl
has to be measured dis-continuoully, so that the experimentally determined peak
leiSht can have any value reached by the curve in the period b'etween one minutebefore and one minute after the real top has been attained.
x'ig.2 shows the data from x'ig. t pl6tted on a semi-logarithmic graph. There seems
to be no reason to consider the great majority of the points along tle d.escending slope
to deviate from a straight line in this kind of graph. This is again shown by x'ig.3,
represenJing experiments canied olut at' 20" C, whereas those shown in Fig. 2 were done
at' 37" C. It is clear from Fig.4 that at both temperatures used the appaient unimole-
cular reaction constant of decay ft.A. in formula (2)] is proportionat io tne antithrom-
bin rrr concentration present (A) and therefore to the plasma dilution used.
X'ig' 5 shows that the virtual thrombin yield at zero time obtained by linear extra-
p_olation to the y-axis in a semi-Iogarithmic graph is almost perfectly proportional to
the filution of the sample at both temperatures tested. The value oitri.r"a with the
undiluted sample was arbitrarily said to contain 100 units. Conversion into N.I.H.-
units is easily done when the thrombin reference curye can be made with a standard.
preparation of thrombin, but no such preparation was available, however.
I
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Fig.2. The thrombin goneration curvo of Fig. 1, plotted in a semi-Iogarithmic graph. I Undiluted
normal plasma sample. O 1:2 dilution. ! 1:3 dilution.
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Fig.3. Thrombin generation,curves in a semi-logarithmic graph. (Experimenfs carried out at 20" C.)
For the sake of clarity, the experimental points are shown only for the undiluted and the 1 :4 dilut-
ed sample. The fuaq.n lines in between represent 2:3, I t2, and 1 : 3 dilutions resp,
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, Antithrombin concentrotion (o/o)
X'ig' 4. R'eaction constant, of decay as a firnction of plasma concentration. (Data obtained from the
experirnents shown in Figs.2 and B.)
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Fig' 5' Extrapolated thrombin yield as a function of plasma concentration. Data from X'ig.2 (black
dots; 37o C) and Fig'3 (open circles;20" C). The valuo obtained wibh the undiluted plasma is
situatod at, point 100 (by definition). This point is thorefore common to both sets of data.
. 
X'ig.6-shows tha-t variation of the antithrombin content causes a proportional varia-tion of the descending slope of the logarithmic graph, but does not aiterihe extrapolat-
ed thrombin yield. The temperaturJdependen-cy if th" d""uy is shorryr in n'ig. z. 
-From
thiy Arrhglius_graph an experimental activatiotr 
"o"rgy of 
-z Kcal p"" -Jl" can be
estimated for the decay reaction; Qro is about 1.b.
Discussion
X'rom the values in Table 1 it is easily seen that both usual ways of evaluating athrombin generation curve are very inexact, and from the theoreticJl considerations it
3 c n
E  - -
u
o
cn
c
:
u
C
O  r n
o  l v
C
b
E
F 5
552
Incubot ion t ime (min)
Fig.6. Thrombin decay curves on a log. scale wifh varying amounts of antithrombin III. An
euglobulin preparat'ion was made that contained 100o/o of factor II. Normal plasma was mixed with
th ispreparat ioninproport ions 1:3 (Q),  and 1:1 ( f ) ,  andalsotestodalone ( f  ) .
X'ig.7. Arrhenius plot of the decay reaction.
can be seen why this is so. The model on which the theoretical considerations are based
considers the thrombin generation cnrve to be the result of:
first: arelatively short thrombin forming reaction, the exact form (i. e. mathematical
description) of rvhich need not to be known for the further development;
anil second: a pseudo-monomolecular breakdown of the thrombin present by anii
thrombin III.
The viability of this model is supported by the finding of :
a) rectilinearity in the descending portion of the thrombin generation curve, when
plotted on a semi-logarithmic scale (n'igs.2 and 3);
l '0
o
o
c
o
0
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o
100071
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b) a proportionality between the pseudo-monomolecular reaction eonstant and the
plasma dilution, i. e. the concentration of antithrombin III (Fig. A) ;
_ _c) a proportionality between the extrapolated thrombin yield and the plasmadilution, i. e. the prothrombin content (Fig.5);
d) independence of the extrapolated. thrombin yield from the slope of the curve,
i. e. from the amount of antithrombin (n'ig.6).
The relatively low activation energy of the antithrombin - thrombin reaction
results in a low Qro ( - 1.5). When the temperature is lowered 10" C, the decay reaction
will slow down about 1.5 times.
Qto of the activation reaction has been found to be between 2.0 and 3.0 (Hemker,
1970), the reaction speed of the thrombin formation will therefore slow down about
2.5 times, when the temperature drops 10' C. Therefore, the assumption that throm-
bin formation is short compared to thrombin decay will hold bettef at higher tempe-
ratures.
It is interesting to note that from a conventional thrombin generation curve the
thrombin formation curve is the strict sense (i. e. without the influence of antithrom-
bin III) can be derived.
X'rom formula (2) it follows that:
e ' t : * *k .A . r  ( z )
dt
k.A. can be estimated from the downslope of the curve on a logarithmic plot. When
T' and T" are two thrombin concentrations found at time t' andt" respectively, then
the velocity of thrombin formation in this interval (Q') can be found by
a' :  T; ; -T '+k.A t " : t '  (8)-  t " - t '  2
This being the equivalent of formula (7) for a discontinuous series of measurements.
Supportive evidence for the correctness of both model and calculation is provided.
by the fact' that, as predicted, the surface area under the curve remains ionstant
vdthin the experimental error, with different dilutions of the same plasma, (Table 1).
The practical consequence of this study is that the prothrombin concentrations in two
stage procedures should be assessed by extrapolation to zero time of the semi-
logarithmis plot of thrombin concentration against incubation time.
Summary
It is shown that (and why) the trafitional ways of evaluating a thrombin generation
curve do not give acceptable estimations of the prothrombin content of the sample. Arr
alternative method is shoum to meet the requirements better; it consists of drawing
ttre thrombin generation curve on a semi-logarithmic graph, and extrapolating the
deseending slope to zero time. This gives a thrombin concentration representing the
prothrombin concentration of the original sample.
R6sume
fl est d6montr6 que les m6thodes traditionnelles d'6valuation de la formation de la
thrombine ne donnent pas une estimation acceptable de la concentration d.e la pro-
th-rombine dans le mat6riel 6tudi6. On indique 6galement la raison d.e ce fait. Une
autre m6thode est d6crite, elle donne des r6sultats plus valables. Elle consiste d faire
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un graphique semilogarithmique de la courbe d.e Ia formation de la thrombine et
extrapolel au temps z6rola partie descendante de la courbe. Cela donne une concen-
tration en thrombine repr6sentan-b la concentration de la prothrombine dans le
mat6riel original.
Zusammenfassung
Es wird gezeigt, daB (und warum) die iibliche Auswertung der Thrombinbildungs-
kurven keine akzeptable Bestimmung des Prothrombingehaltes der Probe gestattet.
Es wird gezeigt,, duB 
"io" 
andere Methode den Erford.ernissen besser gere-cht wird.
Sie besteht darin, daB die Thrombinbildungskurve in einem halblogarithmischen
System gezeichnet und der Abfall auf die Zeit Null extrapoLiert wird. Dies ergibt die
Thrombinkonzentration, die der Prothrombinkonzentration in der Ausgangsprobe
entspricht.
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